In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price ...
Scotiabank analyst Greg Harrison reiterated a Buy rating on Travere Therapeutics (TVTX – Research Report) today and set a price target of ...
Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.82% to $480.33 Thursday, on what proved to be an all-around grim trading ...
Originally scheduled for next week, the meeting of agency advisers will be delayed to give more time for public comment, according to an HHS spokesperson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results